COVAX vaccine 2021 delivery target cut to 1.425 billion doses

Health News
FILE PHOTO: A pack of AstraZeneca/Oxford vaccines is seen as the country receives its first batch of coronavirus disease (COVID-19) vaccines under COVAX scheme, at the international airtport of Accra, Ghana February 24, 2021. REUTERS/Francis Kokoroko/File Photo

(Reuters) – The COVAX vaccine-sharing facility will likely receive 1.425 billion doses of anti-COVID-19 shots from donor countries this year, down from a July estimate of 2 billion, the GAVI Vaccine Alliance said on Wednesday.

Reasons for the cut include export restrictions on key supplier Serum Institute of India (SII), Gavi said in a joint statement with the Coalition for Epidemic Preparedness Innovations (CEPI), the World Health Organization and Unicef.

Manufacturing problems at Johnson & Johnson and AstraZeneca as well as delays in the regulatory review of shots developed by U.S. biotech firm Novavax and China’s Clover Biopharmaceuticals were further limiting factors, the organisations said.

Source: Read Full Article

Related posts:
  1. Vietnam approves AstraZeneca vaccine after new virus outbreak
  2. WHO official says Wuhan probe does not dramatically change picture of outbreak
  3. Ecuador declares state of exception in eight provinces as COVID-19 infections spike
  4. UK reports biggest daily rise in COVID cases since April 27
  5. Spain has already sent 6 million vaccine doses to Latin America, Spokesperson says